MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Saliva swallowing frequency measured using 24-hours ambulatory impedance-pH monitoring in patients with Parkinson’s disease and drooling

J.G. Kalf, S. Scholten, W. Hopman (Nijmegen, Netherlands)

Meeting: 2016 International Congress

Abstract Number: 860

Keywords: Parkinsonism

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To assess the feasibility of using 24-hours ambulatory impedance-pH monitoring (24-hAlpHM) to precisely measure saliva swallowing frequency (SSF) in patients with Parkinson’s disease (PD).

Background: The pathophysiology of drooling is multifactorial, including reduced swallowing capacity, open mouth due to hypomimia, and stooped posture. In addition, it is generally assumed that PD patients also have a reduced SSF prior to the loss of saliva, which generates accumulation of saliva. However, this has not yet been convincingly demonstrated and understood. The main reason for this is that measurement of SSF is only relevant when done during 24 hours in everyday life. Non-invasive SSF-measurements are either limited in time or location or they interfere with other upper airway sounds or body movements. 24-hAlpHM (used to analyze gastro-esophageal reflux) seems suitable for SSF-registration in PD patients.

Methods: Validity of 24-hAlpHM was assessed by one-hour comparison with simultaneous sEMG, acoustic measurement and video in a healthy volunteer. It was then used to measure SSF in five participants having PD and mild to severe drooling for 24 hours, while patients were at home in their daily routine. All saliva swallows were identified and counted. Participants’ opinion on feasibility and burden of the 24-hAlpHM was noted. Intra-rater and inter-rater agreement was assessed using one-hour clips.

Results: Saliva swallow registration with 24-hAlpHM was exactly synchronous with sEMG, acoustics and video. No adverse events were observed or reported and all patients indicated that the measurement was feasible with a reasonable burden. Intra-rater agreement was 91% and inter-rater agreement 86% rising to 93% after discussion. In addition, SSF showed a trend of being lower with increase of drooling: mild (1) = 57.8, moderate (3) = 32.3 and severe (1) = 14.7 swallows/hour (p = 0.11).

Conclusions: 24-hAlpHM is a new technique to safely measure SSF during 24-hours in PD, making it a promising tool to better understand the pathophysiology of drooling and to study possible treatment approaches. The inter-rater agreement can be further improved, but reliability is good when two examiners do the analysis.

This abstract has previously been presented on the 2016 Annual Meeting of the Dysphagia Research Society (February 25 – 27, 2016, Tuscon, Arizona).

To cite this abstract in AMA style:

J.G. Kalf, S. Scholten, W. Hopman. Saliva swallowing frequency measured using 24-hours ambulatory impedance-pH monitoring in patients with Parkinson’s disease and drooling [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/saliva-swallowing-frequency-measured-using-24-hours-ambulatory-impedance-ph-monitoring-in-patients-with-parkinsons-disease-and-drooling/. Accessed June 30, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/saliva-swallowing-frequency-measured-using-24-hours-ambulatory-impedance-ph-monitoring-in-patients-with-parkinsons-disease-and-drooling/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley